id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-281003-7pdhxdzc	Farmakis, Dimitrios	COVID‐19 and thalassaemia: A position statement of the Thalassaemia International Federation	2020-07-13		.txt	text/plain	2829	159	44	METHODS: The present statement summarizes the key challenges concerning the management of haemoglobinopathies, with particular focus on patients with either transfusion‐dependent or non‐transfusion‐dependent thalassaemia, identifies the gaps in knowledge and suggests measures and strategies to deal with the pandemic, based on available evidence and expert opinions. The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected millions across the world, having caused hundreds of thousands deaths. However, disease-related complications may affect multiple organs including the heart, liver, endocrine glands, lungs and the immune system, thus rendering this patient population at an increased risk to develop serious complications during COVID-19. 2, 3, 11 This is especially so in patients who receive suboptimal management and lack access to modern therapy and Thalassaemia patients do not have the same risk of pulmonary infections with sickle cell disease patients but, they may have multiple organ complications, often due to iron overload, including cardiac and hepatic, diabetes mellitus and endocrine disease.	./cache/cord-281003-7pdhxdzc.txt	./txt/cord-281003-7pdhxdzc.txt